Eli Lilly and Co (LLY.N)
A federal appeals court on Wednesday rejected Eli Lilly and Co’s effort to set aside a $20 million jury verdict in a patent lawsuit over the company's erectile dysfunction drug Cialis.
NEW YORK Wall Street stocks stumbled on Thursday as U.S. Treasury yields continued their ascent to multi-year highs on the latest round of strong economic data, building concerns for an acceleration of inflation. | Video
LONDON Hutchison China MediTech has won Chinese approval for a closely watched new cancer drug in a significant boost for "made in China" medicine.
NEW YORK U.S. drug prices fell again in the second quarter, likely due to a new tactic insurers are using to limit financial assistance drugmakers provide directly to consumers, according to research firm Sector and Sovereign Research (SSR).
NEW YORK, Sept 4 U.S. drug prices fell again in the second quarter, likely due to a new tactic insurers are using to limit financial assistance drugmakers provide directly to consumers, according to research firm Sector and Sovereign Research (SSR).
July 24 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Tuesday:
Eli Lilly and Co said on Tuesday it would take its Elanco animal health business public and posted a better-than-expected quarterly profit, helped by demand for its diabetes drugs Trulicity and Humalog.
July 24 Eli Lilly and Co posted a second-quarter loss on Tuesday, hurt by acquisition-related charges to the tune of $1.62 billion.
An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of lowering pain in a late stage trial, the companies said on Wednesday, potentially offering a safer alternative to opioids.
July 18 An experimental drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of reducing pain in osteoarthritis patients in a late stage trial, the companies said on Wednesday.
|Johnson & Johnson (JNJ.N)||$136.56||+2.61|
|Pfizer Inc. (PFE.N)||$43.93||+0.81|
|Novartis AG (NOVN.S)||CHF84.08||+1.62|
|Merck & Co., Inc. (MRK.N)||$71.22||+1.76|
|Abbott Laboratories (ABT.N)||$70.95||+2.25|
|Sanofi SA (SASY.PA)||€76.41||+1.12|
|AstraZeneca plc (AZN.L)||5,763.00||+144.00|
|GlaxoSmithKline plc (GSK.L)||1,486.00||+22.40|
|Bristol-Myers Squibb Co (BMY.N)||$57.83||+0.22|
|Bristol-Myers Squibb Co (BMYMP.PK)||$1,050.20||--|